SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VaxGen Inc.-The 1st AIDS Vaccine in Phase 3 HumanTrials

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: GPSite who wrote (45)6/29/1999 8:36:00 PM
From: glen   of 250
 
I hear that many Prudential offices (and this includes major cities) are getting share allocations only in the low hundreds, for the total individual branches...not thousands. I would guess that between Paul Allen, Bill Gates, all of Pru's institutional clients, and other prior commitments Prudential will need around 2 million shares to satisfy these groups. This would leave about 1,000,000 for the 1200 Pru branch offices, which on average is under 1000 shares/office. Of course, some branches will get more and some less.

So, this will be a tight IPO. Any drug or biotech fund will want to, or will have to have, some exposure to what is the furthest advanced, potential AIDS vaccine in the WORLD. Those not in it will have to buy it in the open market and with a thin float, excitement, volatility, and price appreciation should follow.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext